Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply.
van Kleef LA, de Knegt RJ, Brouwer WP. van Kleef LA, et al. Among authors: de knegt rj. Hepatology. 2023 Mar 1;77(3):E45-E46. doi: 10.1002/hep.32718. Epub 2023 Feb 17. Hepatology. 2023. PMID: 36057078 No abstract available.
Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B.
Brouwer WP, Sonneveld MJ, Tabak F, Simon K, Cakaloglu Y, Akarca US, Zeuzem S, Ferenci P, Heathcote JE, de Knegt RJ, Boonstra A, Hansen BE, Janssen HL. Brouwer WP, et al. Among authors: de knegt rj. Aliment Pharmacol Ther. 2014 Oct;40(7):811-8. doi: 10.1111/apt.12910. Epub 2014 Aug 11. Aliment Pharmacol Ther. 2014. PMID: 25109699 Free article. Clinical Trial.
ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection.
Maan R, van der Meer AJ, Brouwer WP, Plompen EP, Sonneveld MJ, Roomer R, van der Eijk AA, Groothuismink ZM, Hansen BE, Veldt BJ, Janssen HL, Boonstra A, de Knegt RJ. Maan R, et al. Among authors: de knegt rj. PLoS One. 2015 Oct 6;10(10):e0139317. doi: 10.1371/journal.pone.0139317. eCollection 2015. PLoS One. 2015. PMID: 26441325 Free PMC article.
Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen-positive chronic hepatitis B patients.
van Campenhout MJ, Brouwer WP, van Oord GW, Xie Q, Zhang Q, Zhang N, Guo S, Tabak F, Streinu-Cercel A, Wang J, Pas SD, Sonneveld MJ, de Knegt RJ, Boonstra A, Hansen BE, Janssen HL. van Campenhout MJ, et al. Among authors: de knegt rj. Clin Microbiol Infect. 2016 Jun;22(6):571.e5-9. doi: 10.1016/j.cmi.2016.02.002. Epub 2016 Feb 18. Clin Microbiol Infect. 2016. PMID: 26898481 Free article.
Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up.
van Campenhout MJH, Brouwer WP, Xie Q, Guo S, Chi H, Qi X, Tabak F, Streinu-Cercel A, Wang JY, Zhang NP, Idilman R, Reesink HW, Diculescu M, Simon K, Akdogan M, Mazur W, de Knegt RJ, Verhey E, Hansen BE, Janssen HLA; ARES Study Group. van Campenhout MJH, et al. Among authors: de knegt rj. J Viral Hepat. 2019 Jan;26(1):109-117. doi: 10.1111/jvh.12997. Epub 2018 Sep 27. J Viral Hepat. 2019. PMID: 30187612
257 results